Abstract
Eight new sulfonilamidothienopyrimidinone derivatives (1-8) were synthesized and evaluated for their antiinflammatory activity on the human keratinocyte line NCTC 2544. The potential anti-inflammatory activity of the derivatives (1-8) was evaluated by determining, through Western blot, the expression of cyclooxygenase (COX)-2, inducible NO synthase (iNOS), intercellular adhesion molecule-1 (ICAM-1), and the release of prostaglandins (PG)E2 and interleukin- 8 (IL-8). Moreover, through ELISA assay, the release of monocyte chemoattractant protein-1 (MCP-1), and interleukin- 8 (IL-8) was analyzed.
Our results demonstrated that the derivatives 3, 5, 6 and 8 act as excellent inhibitors of inflammatory markers: iNOS, COX-2, ICAM-1, MCP-1, and IL-8. These findings could be useful for the development of new drugs for the treatment of various inflammatory pathologies.
Keywords: Anti-inflammatory activity, cell cultures, COX-2 inhibitors, cytokine, immuno-modulatory membrane molecules, keratinocytes NCTC 2544, nitric oxide, pyrimidin-4-one system.
Medicinal Chemistry
Title:Synthesis and Biological Evaluation of Sulfonilamidothienopyrimidinone Derivatives as Novel Anti-inflammatory Agents
Volume: 10 Issue: 7
Author(s): Mariarita Barone, Andrea Santagati, Adriana C.E. Graziano, Cosimo G. Fortuna, Giuseppe Ronsisvalle and Venera Cardile
Affiliation:
Keywords: Anti-inflammatory activity, cell cultures, COX-2 inhibitors, cytokine, immuno-modulatory membrane molecules, keratinocytes NCTC 2544, nitric oxide, pyrimidin-4-one system.
Abstract: Eight new sulfonilamidothienopyrimidinone derivatives (1-8) were synthesized and evaluated for their antiinflammatory activity on the human keratinocyte line NCTC 2544. The potential anti-inflammatory activity of the derivatives (1-8) was evaluated by determining, through Western blot, the expression of cyclooxygenase (COX)-2, inducible NO synthase (iNOS), intercellular adhesion molecule-1 (ICAM-1), and the release of prostaglandins (PG)E2 and interleukin- 8 (IL-8). Moreover, through ELISA assay, the release of monocyte chemoattractant protein-1 (MCP-1), and interleukin- 8 (IL-8) was analyzed.
Our results demonstrated that the derivatives 3, 5, 6 and 8 act as excellent inhibitors of inflammatory markers: iNOS, COX-2, ICAM-1, MCP-1, and IL-8. These findings could be useful for the development of new drugs for the treatment of various inflammatory pathologies.
Export Options
About this article
Cite this article as:
Barone Mariarita, Santagati Andrea, Graziano C.E. Adriana, Fortuna G. Cosimo, Ronsisvalle Giuseppe and Cardile Venera, Synthesis and Biological Evaluation of Sulfonilamidothienopyrimidinone Derivatives as Novel Anti-inflammatory Agents, Medicinal Chemistry 2014; 10 (7) . https://dx.doi.org/10.2174/1573406410666140228152807
DOI https://dx.doi.org/10.2174/1573406410666140228152807 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
Call for Papers in Thematic Issues
Biomolecules in Medicinal and Pharmaceutical Chemistry for Drug Development
Medicinal chemists play a vital role in the drug development process by identifying and synthesizing molecules that define structure-activity correlations and ensure efficacy and safety in preclinical animal testing. The fields of medicinal chemistry and pharmaceutical chemistry constitute an analogy that has the potential to encourage a beneficial relationship between ...read more

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Difluorinated Curcumin: A Promising Curcumin Analogue with Improved Anti-Tumor Activity and Pharmacokinetic Profile
Current Pharmaceutical Design HIV-1 Matrix Protein p17 and its Receptors
Current Drug Targets Cardiovascular Effects of Phosphodiesterase 5 Inhibitors
Current Pharmaceutical Design Novel Research Strategies of Benzimidazole Derivatives: A Review
Mini-Reviews in Medicinal Chemistry Identification of Novel 5,6-Dimethoxyindan-1-one Derivatives as Antiviral Agents
Medicinal Chemistry Imaging of Hypoxia Using PET and MRI
Current Pharmaceutical Biotechnology Development of Peptide and Protein Based Radiopharmaceuticals
Current Pharmaceutical Design The Synthetic and Biological Attributes of Pyrazole Derivatives: A Review
Mini-Reviews in Medicinal Chemistry Structure-based Design of Mimetics for Granulocyte-macrophage Colony Stimulating Factor (GM-CSF)
Current Pharmaceutical Design Influencing COX-2 Activity by COX Related Pathways in Inflammation and Cancer
Mini-Reviews in Medicinal Chemistry Peptides and Small Molecules Targeting the Plasminogen Activation System: Towards Prophylactic Anti-Metastasis Drugs for Breast Cancer
Recent Patents on Anti-Cancer Drug Discovery Circulating Tumor Cells in Cancer Therapy: Are we off Target?
Current Cancer Drug Targets Chromosome Engineering and ENU Mutagenesis: Their Use for Defining Gene Function
Current Genomics Inactivation of Parathyroid Hormone: Perspectives of Drug Discovery to Combating Hyperparathyroidism
Current Molecular Pharmacology Cardioprotective effects of Aronia melanocarpa anthocynanins. From laboratory experiments to clinical practice.
Current Pharmaceutical Design Extrapulmonary Tuberculosis- Its Management and Control
Current Drug Therapy Drugs in Newborn Resuscitation: The More We Learn the Least We Use
Current Medicinal Chemistry Antiglycation Activity of Triazole Schiff’s Bases Against Fructosemediated Glycation: In Vitro and In Silico Study
Medicinal Chemistry The Prostaglandin Agonist Beraprost Aggravates Doxorubicin-mediated Apoptosis by Increasing iNOS Expression in Cardiomyocytes
Current Vascular Pharmacology Chemical Instability Determines the Biological Action of the Artemisinins
Current Medicinal Chemistry